George Wilding
Impact in
- Pulmonary and Respiratory Medicine top 0.02%
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
- Prostate Cancer Diagnosis and Treatment
- Cancer Research top 0.1%
- Cancer Genomics and Diagnostics
- Cancer, Lipids, and Metabolism
Papers in
-
- Prostate Cancer Treatment and Research 67
- Renal cell carcinoma treatment 35
- Lung Cancer Treatments and Mutations 12
- Co-authors
- Robert J. Motzer (21 shared papers)Judith Manola (25 shared papers)M. Dror Michaelson (16 shared papers)Edward M. Messing (12 shared papers)Gary R. Hudes (13 shared papers)Glenn Liu (49 shared papers)Donald L. Trump (7 shared papers)Brian I. Rini (12 shared papers)
- Journals
- Journal of Clinical Oncology (78 papers)Cancer Chemotherapy and Pharmacology (25 papers)Investigational New Drugs (24 papers)Clinical Cancer Research (19 papers)Cancer (15 papers)
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
George Wilding
306 papers receiving 22.6k citations
George Wilding's Hit Papers
Peers
Comparison fields: 5 of 154
- Pulmonary and Respiratory Medicine 10.9k
- Cancer Research 4.1k
- Oncology 5.3k
- Molecular Biology 8.4k
- Toxicology 271
Countries citing papers authored by George Wilding
This map shows the geographic impact of George Wilding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Wilding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Wilding more than expected).
Fields of papers citing papers by George Wilding
This network shows the impact of papers produced by George Wilding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Wilding. The network helps show where George Wilding may publish in the future.
Co-authors
The 25 scholars most cited alongside George Wilding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 314 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma Hit paper breakdown → | 2009 | 1773 |
| 2 | Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group Hit paper breakdown → | 2008 | 1740 |
| 3 | Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma Hit paper breakdown → | 2005 | 1360 |
| 4 | Sunitinib in Patients With Metastatic Renal Cell Carcinoma Hit paper breakdown → | 2006 | 1010 |
| 5 | Immediate Hormonal Therapy Compared with Observation after Radical Prostatectomy and Pelvic Lymphadenectomy in Men with Node-Positive Prostate Cancer Hit paper breakdown → | 1999 | 953 |
| 6 | Bilateral Orchiectomy with or without Flutamide for Metastatic Prostate Cancer Hit paper breakdown → | 1998 | 713 |
| 7 | Therapy-Induced Senescence in Cancer Hit paper breakdown → | 2010 | 662 |
| 8 | Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy Hit paper breakdown → | 2006 | 653 |
| 9 | 2005 | 430 | |
| 10 | 2006 | 379 | |
| 11 | 2007 | 365 | |
| 12 | 1990 | 363 | |
| 13 | 2009 | 285 | |
| 14 | 1997 | 281 | |
| 15 | 2000 | 225 | |
| 16 | 2005 | 220 | |
| 17 | 2003 | 218 | |
| 18 | 2012 | 214 | |
| 19 | 2004 | 202 | |
| 20 | 2009 | 199 |
About George Wilding
George Wilding is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research and Surgery, having authored 314 papers that have together received 23.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (67 papers), Renal cell carcinoma treatment (35 papers), Cancer Treatment and Pharmacology (24 papers), Cancer Genomics and Diagnostics (21 papers), Colorectal Cancer Treatments and Studies (14 papers), Bladder and Urothelial Cancer Treatments (13 papers), Estrogen and related hormone effects (13 papers) and Lung Cancer Treatments and Mutations (12 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (10.9k citations), Cancer Research (4.1k citations), Oncology (5.3k citations), Molecular Biology (8.4k citations) and Toxicology (271 citations). George Wilding has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Robert J. Motzer, Judith Manola, M. Dror Michaelson, Edward M. Messing, Gary R. Hudes, Glenn Liu, Donald L. Trump, Brian I. Rini, Sindy T. Kim and Ronald M. Bukowski. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Investigational New Drugs, Clinical Cancer Research and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.